ImmunityBio (IBRX) Cash & Equivalents Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.65% |
| Dec 31, 2025 | 20.40% |
| Sep 30, 2025 | -6.58% |
| Jun 30, 2025 | 3.63% |
| Mar 31, 2025 | 0.67% |
| Dec 31, 2024 | 13.60% |
| Sep 30, 2024 | 43.67% |
| Jun 30, 2024 | 49.75% |
| Mar 31, 2024 | 42.96% |
| Dec 31, 2023 | 73.63% |
| Sep 30, 2023 | 63.33% |
| Jun 30, 2023 | 21.96% |
| Mar 31, 2023 | 51.20% |
| Dec 31, 2022 | 34.39% |
| Sep 30, 2022 | 45.23% |
| Jun 30, 2022 | 9.66% |
| Mar 31, 2022 | 21.76% |
| Dec 31, 2021 | 86.24% |
| Sep 30, 2021 | 15.49% |
| Jun 30, 2021 | 17.04% |
| Mar 31, 2021 | -6.72% |
| Dec 31, 2020 | -27.63% |
| Sep 30, 2020 | -25.07% |
| Jun 30, 2020 | -0.89% |
| Mar 31, 2020 | 3.30% |
| Dec 31, 2019 | 5.10% |
| Sep 30, 2019 | 41.90% |
| Jun 30, 2019 | 34.05% |
| Dec 31, 2018 | 116.95% |